Hellp Syndrome
What's New
Last Posted: May 04, 2024
- Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study.
Theodora-Maria Venou, et al. Journal of personalized medicine 2024 0 (4) - STOX1 promotor region -922 T?>?C polymorphism is associated with Early-Onset preeclampsia.
Akin Seyda, et al. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 2022 0 1-7 - Quantitative Alterations in Complement Alternative Pathway and Related Genetic Analysis in Severe Phenotype Preeclampsia.
Alrahmani Layan, et al. Kidney360 2022 0 (9) 1463-1472 - Genetic association of ERAP1 and ERAP2 with eclampsia and preeclampsia in northeastern Brazilian women.
Ferreira Leonardo Capistrano, et al. Scientific reports 2021 3 (1) 6764 - PHLDA2 gene polymorphisms and risk of HELLP syndrome and severe preeclampsia.
Ding Li, et al. Pregnancy hypertension 2020 1 190-194 - Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
Rovelli Valentina et al. Molecular genetics and metabolism 2019 Apr - FAS A-670G and Fas ligand IVS2nt A 124G polymorphisms are significantly increased in women with pre-eclampsia and may contribute to HELLP syndrome: a case-controlled study.
Raguema N, et al. BJOG : an international journal of obstetrics and gynaecology 2018 8 - Germline mutations in the alternative pathway of complement predispose to HELLP syndrome.
Vaught Arthur J, et al. JCI insight 2018 3 (6) - The maternal 14 bp Ins/Del polymorphism in HLA-G is not associated with preeclampsia risk.
Ferreira L C, et al. International journal of immunogenetics 2017 11 - Association of Nitric Oxide Synthase and Matrix Metalloprotease Single Nucleotide Polymorphisms with Preeclampsia and Its Complications.
Leonardo Daniela P, et al. PloS one 2015 0 (8) e0136693
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: